Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Sales | 71,859 | 59,801 | 0 | 53,741 | 0 |
| Cost of Goods | 33,677 | 33,562 | N/A | 21,464 | N/A |
| Gross Profit | 38,182 | 26,239 | N/A | 32,277 | N/A |
| Operating Expenses | 26,219 | 27,898 | 0 | 50,963 | 0 |
| Operating Income | 12,640 | -1,097 | N/A | -18,222 | N/A |
| Interest Expense | 5,241 | 4,843 | 0 | 7,301 | 0 |
| Other Income | 309 | 137 | 0 | 1,203 | 0 |
| Pre-tax Income | 7,708 | -5,803 | 0 | -24,320 | 0 |
| Income Tax | 1,819 | -1,195 | N/A | -12,047 | N/A |
| Net Income Continuous | 5,888 | -4,607 | N/A | -12,273 | N/A |
| Net Income | $5,888 | $-4,607 | $N/A | $-12,273 | $N/A |
| EPS Basic Total Ops | 0.14 | -0.11 | N/A | -12.27 | N/A |
| EPS Basic Continuous Ops | 0.14 | -0.11 | N/A | -12.26 | N/A |
| EPS Diluted Total Ops | 0.14 | -0.11 | N/A | -12.27 | N/A |
| EPS Diluted Continuous Ops | 0.14 | -0.11 | N/A | -12.26 | N/A |
| EBITDA(a) | $32,677 | $19,732 | $N/A | $-18,222 | $N/A |